Arai Hidenori
National Center for Geriatrics and Gerontology, Obu, Japan.
JMA J. 2020 Apr 15;3(2):95-100. doi: 10.31662/jmaj.2019-0032. Epub 2020 Mar 6.
In aging societies, sarcopenia is considered to be a significant threat for the elderly and for people with multimorbidities. Although several diagnostic algorithms are currently available, no guidelines are so far available for the prevention and intervention of sarcopenia. Therefore, we decided to publish clinical sarcopenia guidelines by collaboration with the Japanese Association on Sarcopenia and Frailty, the Japan Geriatrics Society, and the National Center for Geriatrics and Gerontology to provide tools for clinical practice. We published a Japanese version in December 2017 and an English version in May 2018. This article is a summary of these clinical sarcopenia guidelines. As the disease code of sarcopenia is available in Japan, these guidelines would be useful for many healthcare professionals and can be used for the prevention of disabilities in the elderly.
在老龄化社会中,肌肉减少症被认为是对老年人和患有多种疾病的人的重大威胁。尽管目前有几种诊断算法,但迄今为止尚无关于肌肉减少症预防和干预的指南。因此,我们决定与日本肌肉减少症和衰弱症协会、日本老年医学会以及国立老年医学和老年学中心合作发布临床肌肉减少症指南,以提供临床实践工具。我们于2017年12月发布了日文版,2018年5月发布了英文版。本文是这些临床肌肉减少症指南的总结。由于日本有肌肉减少症的疾病编码,这些指南将对许多医疗保健专业人员有用,并可用于预防老年人的残疾。